BioNTech halts colorectal cancer vaccine trial after safety review finds treatment unlikely to extend survival
BioNTech ended a mid-stage study of its experimental mRNA cancer vaccine after an independent committee determined the treatment was unlikely to help colorectal cancer patients live longer.
2 sourcesCancer immunotherapy
00